Charles River Laboratories (CRL)
Cash ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 276,771 | 157,174 | 200,445 | 201,587 | 233,912 | 193,701 | 200,321 | 241,869 | 241,214 | 212,539 | 222,969 | 465,411 | 228,424 | 242,879 | 402,020 | 372,433 | 238,014 | 164,759 | 200,589 | 126,316 |
Short-term investments | US$ in thousands | — | 944 | 951 | 1,001 | 998 | 950 | 1,012 | 1,065 | 1,063 | 1,030 | 1,037 | 1,025 | 1,024 | 963 | 929 | 934 | 941 | 855 | 887 | 907 |
Total current liabilities | US$ in thousands | 1,055,080 | 993,816 | 1,007,620 | 981,392 | 1,091,580 | 1,014,190 | 1,048,140 | 993,839 | 1,033,180 | 983,751 | 929,610 | 803,376 | 839,751 | 787,014 | 727,936 | 690,896 | 710,181 | 681,646 | 635,598 | 529,759 |
Cash ratio | 0.26 | 0.16 | 0.20 | 0.21 | 0.22 | 0.19 | 0.19 | 0.24 | 0.23 | 0.22 | 0.24 | 0.58 | 0.27 | 0.31 | 0.55 | 0.54 | 0.34 | 0.24 | 0.32 | 0.24 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($276,771K
+ $—K)
÷ $1,055,080K
= 0.26
The cash ratio of Charles River Laboratories has shown some fluctuations over the past few quarters. The cash ratio measures the company's ability to cover its short-term liabilities using cash and cash equivalents, with a higher ratio indicating a stronger liquidity position.
Looking at the trend, we observe that the cash ratio has ranged between 0.16 and 0.58 over the past five quarters. The ratio reached its highest level in the first quarter of 2021 at 0.58, indicating a substantial cash position relative to its short-term obligations. However, the ratio then declined sharply in subsequent quarters before stabilizing around 0.20 to 0.26 in the most recent quarters.
Overall, Charles River Laboratories has maintained a reasonable cash ratio above 0.2, indicating that it has enough cash on hand to cover its immediate financial obligations. It is important for the company to monitor its cash ratio closely to ensure it maintains adequate liquidity for operational needs and unforeseen expenses.
Peer comparison
Dec 31, 2023